共 50 条
- [1] Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 YearsMMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2017, 66 (27): : 728 - 733Black, Carla L.Williams, Walter W.Warnock, RobPilishvili, TamaraKim, DavidKelman, Jeffrey A.
- [2] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2014, 63 (37): : 822 - 825Tomczyk, SaraBennett, Nancy M.Stoecker, CharlesGierke, RyanMoore, Matthew R.Whitney, Cynthia G.Hadler, StephenPilishvili, Tamara
- [3] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization PracticesMMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (46): : 1069 - 1075Matanock, AlmeaLee, GraceGierke, RyanKobayashi, MiwakoLeidner, AndrewPilishvili, Tamara
- [5] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (01) : 232 - 235Bennett, Nancy M.Whitney, Cynthia G.Moore, MattPilishvili, TamaraDooling, Kathleen L.
- [6] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices (vol 68, pg 1074, 2019)MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 68 (51-52): : 1195 - 1195Bennett, NancyFarley, Monica
- [8] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6-18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (25): : 521 - 524Bennett, Nancy M.Pilishvili, TamaraWhitney, Cynthia G.Moore, MatthewGierke, RyanHarris, Aaron M.
- [9] PHARMACOECONOMIC EVALUATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CANADIAN ADULTSVALUE IN HEALTH, 2012, 15 (04) : A243 - A243Chuck, A.Waye, A.Zanotti, G.Jacobs, P.Kellner, J.Tyrrell, G.
- [10] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adultsVACCINE, 2013, 31 (35) : 3577 - 3584Jackson, Lisa A.Gurtman, Alejandravan Cleeff, MartinJansen, Kathrin U.Jayawardene, DeepthiDevlin, CarmelScott, Daniel A.Emini, Emilio A.Gruber, William C.Schmoele-Thoma, Beate